A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+12.81%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
AUM
$112M
AUM Growth
+$112M
Cap. Flow
+$856K
Cap. Flow %
0.77%
Top 10 Hldgs %
97.03%
Holding
19
New
3
Increased
2
Reduced
2
Closed
5
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.71B
$41.8M 37.43% 1,171,268
SIEN
2
DELISTED
Sientra, Inc.
SIEN
$20.5M 18.32% 2,390,843 +191,831 +9% +$1.64M
CHMA
3
DELISTED
Chiasma, Inc. Common Stock
CHMA
$10.7M 9.57% 2,080,595
SLNO icon
4
Soleno Therapeutics
SLNO
$3.6B
$9.62M 8.61% 4,669,272
AVDR
5
DELISTED
Avedro, Inc Common Stock
AVDR
$8.73M 7.82% +719,402 New +$8.73M
PRTK
6
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$5.59M 5% 1,041,131
VRNA
7
Verona Pharma
VRNA
$9.16B
$5.5M 4.92% 901,943
SRRA
8
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.31M 2.06% 1,365,027 -79,418 -5% -$134K
SYRE icon
9
Spyre Therapeutics
SYRE
$996M
$1.93M 1.73% +240,500 New +$1.93M
CBAY
10
DELISTED
Cymabay Therapeutics
CBAY
$1.74M 1.56% 131,036
OBSV
11
DELISTED
ObsEva SA Ordinary Shares
OBSV
$1.12M 1% 87,999 -352,001 -80% -$4.47M
TARA icon
12
Protara Therapeutics
TARA
$120M
$1.01M 0.9% 2,017,872
RLM
13
DELISTED
Realm Therapeutics plc American Depositary Shares
RLM
$988K 0.88% +255,371 New +$988K
OCGN icon
14
Ocugen
OCGN
$319M
$206K 0.18% 1,777,778 +888,889 +100% +$103K
ADAP
15
Adaptimmune Therapeutics
ADAP
$15.6M
-250,000 Closed -$1.44M
AUPH icon
16
Aurinia Pharmaceuticals
AUPH
$1.58B
-400,434 Closed -$2.72M
CLLS
17
Cellectis
CLLS
$258M
-100,000 Closed -$1.66M
RARE icon
18
Ultragenyx Pharmaceutical
RARE
$2.89B
-38,100 Closed -$1.66M
IMDZ
19
DELISTED
Immune Design Corp.
IMDZ
-352,300 Closed -$458K